Serum Leptin Might Be Causally Correlated to Invasive Ductal Breast Carcinoma

S. Al-Shibli, N. M. Amjad, Muna Khaleel Dheyab Al-Kubaisi, Norra Harun, Emad M. Nafie, S. Mizan
{"title":"Serum Leptin Might Be Causally Correlated to Invasive Ductal Breast Carcinoma","authors":"S. Al-Shibli, N. M. Amjad, Muna Khaleel Dheyab Al-Kubaisi, Norra Harun, Emad M. Nafie, S. Mizan","doi":"10.4172/2324-9110.1000211","DOIUrl":null,"url":null,"abstract":"Introduction: Leptin, the hormone secreted from white adipose tissue is suspected of being a causative factor in tumorigenesis in various tissues. Thus it might be a link between obesity and breast cancer. \nObjectives: In this project we tried to study causative association of obesity and serum leptin with invasive ductal breast cancer (IDC) in a sample of Malaysian population. \nMethods: We measured various obesity parameters, and estimated serum leptin levels in a group of healthy control and IDC patients. After confirming diagnosis by standard histopathological methods, serum leptin levels were estimated using ELISA. Both the pre-and postoperative leptin levels were measured with the Patient group. \nResults: The difference between the serum leptin levels of the Control and the Patient group were highly significant with a P value of 0.05). \nConclusion: Since high serum leptin in IDC patients persists unabated in the post-operative state, we infer that the source of leptin in these cases cannot be the breast cancer tissue itself and leptin cannot be a marker for breast cancer. Highly significant association between serum leptin and IDC patients suggests that leptin in serum might play a causative role in the tumorigenesis of breast cancer, and it might be an important connection between obesity and breast cancer. Therefore, leptin signal transduction pathway might be a prospective therapeutic target in the treatment and prevention of IDC.","PeriodicalId":73658,"journal":{"name":"Journal of clinical & experimental oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical & experimental oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2324-9110.1000211","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: Leptin, the hormone secreted from white adipose tissue is suspected of being a causative factor in tumorigenesis in various tissues. Thus it might be a link between obesity and breast cancer. Objectives: In this project we tried to study causative association of obesity and serum leptin with invasive ductal breast cancer (IDC) in a sample of Malaysian population. Methods: We measured various obesity parameters, and estimated serum leptin levels in a group of healthy control and IDC patients. After confirming diagnosis by standard histopathological methods, serum leptin levels were estimated using ELISA. Both the pre-and postoperative leptin levels were measured with the Patient group. Results: The difference between the serum leptin levels of the Control and the Patient group were highly significant with a P value of 0.05). Conclusion: Since high serum leptin in IDC patients persists unabated in the post-operative state, we infer that the source of leptin in these cases cannot be the breast cancer tissue itself and leptin cannot be a marker for breast cancer. Highly significant association between serum leptin and IDC patients suggests that leptin in serum might play a causative role in the tumorigenesis of breast cancer, and it might be an important connection between obesity and breast cancer. Therefore, leptin signal transduction pathway might be a prospective therapeutic target in the treatment and prevention of IDC.
血清瘦素可能与浸润性乳腺导管癌相关
引言:白脂肪组织分泌的瘦素被怀疑是多种组织肿瘤发生的致病因素。因此,它可能是肥胖和癌症之间的联系。目的:在本项目中,我们试图研究马来西亚人群中肥胖和血清瘦素与癌症浸润性导管癌(IDC)的发病关系。方法:我们测量了一组健康对照组和IDC患者的各种肥胖参数,并估计了血清瘦素水平。在通过标准组织病理学方法确认诊断后,使用ELISA估计血清瘦素水平。患者组测量术前和术后瘦素水平。结果:对照组与患者组血清瘦素水平差异有显著性(P值0.05)。血清瘦素与IDC患者有高度显著的相关性,提示血清瘦素可能在乳腺癌症的肿瘤发生中起着重要作用,可能是肥胖与癌症之间的重要联系。因此,瘦素信号转导通路可能是治疗和预防IDC的一个有前景的治疗靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信